Losartan Potassium Tablet, Film Coated
Product Images NDC 71205-281

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71205-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Losartan Fig1)

A line graph comparing the percentage of patients with primary endpoint events over 66 months between Losartan Potassium and Atenolol. The graph shows cumulative event rates increasing over time for both drugs, with a noted adjusted risk reduction of 13% and a p-value of 0.021 favoring Losartan Potassium.*

FDA Label Image

Figure2 (Losartan Fig2)

A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over 66 study months for Atenolol and Losartan Potassium. The graph shows lines for both drugs with Losartan Potassium indicating a 25% adjusted risk reduction in stroke, statistically significant with p=0.001.*

FDA Label Image

Figure 3 (Losartan Fig3)

A forest plot figure titled 'Primary Endpoint Events within Demographic Subgroups' showing hazard ratios with 95% confidence intervals comparing Losartan Potassium and Atenolol. The plot displays primary composite and stroke (fatal/non-fatal) event rates in percentages for various subgroups defined by age, gender, race, isolated systolic hypertension (ISH), diabetes, and history of cardiovascular disease (CVD), with markers indicating whether outcomes favor Losartan Potassium or Atenolol.*

FDA Label Image

Figure-4 (Losartan Fig4)

A line graph showing the percentage of patients with an event over 48 months comparing Losartan Potassium (solid line) and placebo (dashed line). The graph indicates a risk reduction of 16.1% with Losartan Potassium and a p-value of 0.022.*

FDA Label Image

71205-281-30 (Losartan Fig6)

Packaging label for Losartan Potassium 50 mg film-coated tablets, containing 90 tablets per package. The label displays instructions that each tablet contains 50 mg of Losartan Potassium USP. Tablets are described as green, oval, biconvex film-coated tablets with specific debossing. The product is labeled by Proficient Rx LP, with manufacturing by Aurobindo Pharma Limited, Hyderabad, India. Storage temperature and caution to keep medication out of children's reach are noted.*

FDA Label Image

Chemical Structure (Losartan Str)

Chemical structure of Losartan Potassium, showing its molecular configuration including the potassium ion (K+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.